The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Pediatric Drug Formulations: A Review of Challenges and Progress
Open accessAbstract
Children differ from adults in many aspects of pharmacotherapy, including capabilities for drug administration, medicine-related toxicity, and taste preferences. It is essential that pediatric medicines are formulated to best suit a child’s age, size, physiologic condition, and treatment requirements. To ensure adequate treatment of all children, different routes of administration, dosage forms, and strengths may be required. Many existing formulations are not suitable for children, which often leads to off-label and unlicensed use of adult medicines. New regulations, additional funding opportunities, and innovative collaborative research initiatives have resulted in some recent progress in the development of pediatric formulations. These advances include a paradigm shift toward oral solid formulations and a focus on novel preparations, including flexible, dispersible, and multiparticulate oral solid dosage forms. Such developments have enabled greater dose flexibility, easier administration, and better acceptance of drug formulations in children. However, new pediatric formulations address only a small part of all therapeutic needs in children; moreover, they are not always available. Five key issues need to be addressed to stimulate the further development of better medicines for children: (1) the continued prioritization of unmet formulation needs, particularly drug delivery in neonates and treatment gaps in pediatric cancers and childhood diseases in developing countries; (2) a better use of existing data to facilitate pediatric formulation development; (3) innovative technologies in adults that can be used to develop new pediatric formulations; (4) clinical feedback and practice-based evidence on the impact of novel formulations; and (5) improved access to new pediatric formulations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
Kearns, G. L., Abdel-Rahman, S. M., Alander, S. W., Blowey, D. L., Leeder, J. S., & Kauffman, R. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra035092 · Cited by 2,421
Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications
Menjoge, A. R., Kannan, R. M., & Tomalia, D. A. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.01.009 · Cited by 795
Bartelink, I. H., Rademaker, C. M. A., Schobben, A. F. A. M., & van den Anker, J. N. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645110-00003 · Cited by 418
Self-citationFATAL BENZYL ALCOHOL POISONING IN A NEONATAL INTENSIVE CARE UNIT
Brown, W., Buist, N. M., Cory Gipson, H., Huston, R., & Kennaway, N. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92377-7 · Cited by 397
Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults
Fernandez, E., Perez, R., Hernandez, A., Tejada, P., Arteta, M., & Ramos, J. T. (2011) · Pharmaceutics · doi:10.3390/pharmaceutics3010053 · Cited by 370
Editorial comment: Therapeutic orphans
Shirkey, H. (1968) · The Journal of Pediatrics · doi:10.1016/s0022-3476(68)80414-7 · Cited by 359
A literature review on off-label drug use in children
Pandolfini, C., & Bonati, M. (2005) · European Journal of Pediatrics · doi:10.1007/s00431-005-1698-8 · Cited by 346
Extrapolation of Adult Data and Other Data in Pediatric Drug-Development Programs
Dunne, J., Rodriguez, W. J., Murphy, M. D., Beasley, B. N., Burckart, G. J., Filie, J. D., Lewis, L. L., Sachs, H. C., Sheridan, P. H., Starke, P., et al. (2011) · Pediatrics · doi:10.1542/peds.2010-3487 · Cited by 318
Pediatric Exposure and Potential Toxicity of Phthalate Plasticizers
Shea, K. M., & Committee on Environmental Health (2003) · Pediatrics · doi:10.1542/peds.111.6.1467 · Cited by 310
Formulation of medicines for children
Nunn, T., & Williams, J. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02410.x · Cited by 272
Cited by
Lopez, F. L., Ernest, T. B., Tuleu, C., & Gul, M. O. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1060218 · Cited by 265
Rampedi, P. N., Ogunrombi, M. O., & Adeleke, O. A. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16060712 · Cited by 15
Metadata
- Authors
- Ivanovska, V., Rademaker, C. M. A., van Dijk, L., & Mantel-Teeuwisse, A. K.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2014-08-01
- Volume
- 134
- Issue
- 2
- Pages
- 361-372
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2157788227
- Cited by
- 324
- References
- 44
- FWCI
- 18.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pediatric Drug Formulations: A Review of Challenges and Progress. https://app.cochat.ai/papers/10.1542/peds.2013-3225
- The paper
- Ivanovska, V., Rademaker, C. M. A., van Dijk, L., & Mantel-Teeuwisse, A. K. (2014). Pediatric Drug Formulations: A Review of Challenges and Progress. Pediatrics. https://doi.org/10.1542/peds.2013-3225
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.